Enanta Pharmaceuticals, Inc. (ENTA) Social Stream



Enanta Pharmaceuticals, Inc. (ENTA): $12.03

0.05 (-0.41%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ENTA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#99 of 360

in industry

ENANTA PHARMACEUTICALS INC (ENTA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ENTA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 10 $121 $55 $89.777 $12.04 645.66%
2021-11-19 10 $121 $55 $89.555 $12.04 643.81%
2021-11-22 10 $111 $55 $88.444 $12.04 634.58%
2021-11-23 10 $111 $71 $89.666 $12.04 644.73%
2022-01-06 9 $116 $71 $89.555 $12.04 643.81%
2022-01-13 9 $116 $71 $89 $12.04 639.2%
2022-02-02 8 $116 $71 $89 $12.04 639.2%
2022-02-08 9 $116 $72 $91.25 $12.04 657.89%
2022-02-16 8 $116 $68 $88.875 $12.04 638.16%
2022-05-10 8 $116 $68 $87 $12.04 622.59%
2022-05-11 8 $116 $58 $81.5 $12.04 576.91%
2022-05-19 8 $116 $44 $76 $12.04 531.23%
2022-05-20 8 $116 $44 $73.222 $12.04 508.16%
2022-06-01 8 $116 $39 $69.777 $12.04 479.54%
2022-06-02 9 $116 $39 $69.8 $12.04 479.73%
2022-07-21 8 $116 $44 $71.777 $12.04 496.15%
2022-08-01 8 $116 $50 $73.333 $12.04 509.08%
2022-08-09 8 $116 $50 $73.222 $12.04 508.16%
2022-11-09 8 $137 $50 $76.222 $12.04 533.07%
2022-11-22 8 $137 $50 $74.888 $12.04 521.99%
2022-11-23 8 $137 $50 $73.888 $12.04 513.69%
2022-12-09 9 $137 $50 $72.1 $12.04 498.84%
2023-01-27 9 $137 $49 $72 $12.04 498.01%
2023-02-07 9 $137 $49 $72.3 $12.04 500.5%
2023-03-22 9 $137 $49 $72.1 $12.04 498.84%
2023-05-09 9 $137 $37 $68.9 $12.04 472.26%
2023-05-11 9 $87 $30 $52.333 $12.04 334.66%
2023-07-17 7 $65 $27 $44.571 $12.04 270.19%
2023-08-08 7 $65 $18 $39.857 $12.04 231.04%
2023-08-09 7 $48 $14 $28.142 $12.04 133.74%
2023-10-02 7 $48 $14 $26.714 $12.04 121.88%
2023-10-20 7 $48 $14 $25.142 $12.04 108.82%
2023-11-20 7 $42 $14 $22.571 $12.04 87.47%
2023-11-21 7 $30 $14 $19.857 $12.04 64.93%
2023-11-22 8 $28 $12 $18.714 $12.04 55.43%

The Trend in the Analyst Price Target


Over the past 19 months, ENTA's average price target has gone down $66.66.

Over the past 43 weeks, ENTA's average upside potential has been 106.75%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-27 9 137 49 72.000 52.02 38.41%
2023-02-14 9 137 49 72.100 49.76 44.9%
2023-05-11 9 65 30 48.000 25.52 88.09%
2023-08-08 7 65 18 39.857 18.52 115.21%
2023-11-20 7 42 14 22.571 8.94 152.47%

ENTA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.71 2 0 4 1 1 7

The Trend in the Broker Recommendations


ENTA's average broker recommendation rating worsened by 0.71 over the prior 18 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, ENANTA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 4191.52% of them.
  • In the context of all US stocks, ENANTA PHARMACEUTICALS INC's variance in analysts' estimates is lower than -3729.11% of them.
  • ENANTA PHARMACEUTICALS INC's average analyst price target is higher than 3339.99% of Pharmaceutical Products stocks.
  • In terms of how ENANTA PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 2623.57% of that group.

In the Pharmaceutical Products industry, MDGL, MGNX, and CYRX are the three stocks most similar to ENANTA PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding ENTA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!